Published online before print August 26, 2002, doi: 10.1161/01.HYP.0000032940.33466.12
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:441.)
© 2002 American Heart Association, Inc.
Brief Review |
Obesity Hypertension in Children
A Problem of Epidemic Proportions
From the Division of Pediatric Nephrology and Hypertension, Department of Pediatrics, University of Texas-Houston Medical School (J.S.), Houston, Tex; and Division of Cardiology, Department of Pediatrics, University of Cincinnati, College of Medicine and the Children’s Hospital Medical Center (S.D.), Cincinnati, Ohio.
Correspondence to Jonathan M. Sorof, MD, Associate Professor, Division of Pediatric Nephrology and Hypertension, University of Texas-Houston, Medical School, 6431 Fannin St, Rm 3.124, Houston, TX 77030. E-mail jonathan.m.sorof{at}uth.tmc.edu
 |
Abstract |
|---|
 Top Abstract IntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
Obesity has become an increasingly important medical problem in children and adolescents. In national surveys from the 1960s to the 1990s, the prevalence of overweight in children grew from 5% to 11%. Outcomes related to childhood obesity include hypertension, type 2 diabetes mellitus, dyslipidemia, left ventricular hypertrophy, nonalcoholic steatohepatitis, obstructive sleep apnea, orthopedic problems, and psychosocial problems. Once considered rare, primary hypertension in children has become increasingly common in association with obesity and other risk factors, including a family history of hypertension and an ethnic predisposition to hypertensive disease. Obese children are at approximately a 3-fold higher risk for hypertension than nonobese children. In addition, the risk of hypertension in children increases across the entire range of body mass index (BMI) values and is not defined by a simple threshold effect. As in adults, a combination of factors including overactivity of the sympathetic nervous system (SNS), insulin resistance, and abnormalities in vascular structure and function may contribute to obesity-related hypertension in children. The benefits of weight loss for blood pressure reduction in children have been demonstrated in both observational and interventional studies. Obesity in childhood should be considered a chronic medical condition that is likely to require long-term management. Ultimately, prevention of obesity and its complications, including hypertension, is the goal.
Key Words: hypertension, obesity • children • epidemiology • cardiovascular diseases • risk factors
|
Introduction |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
Obesity has become an increasingly important medical problem in children and adolescents. Many of the outcomes associated with obesity that were previously thought of as diseases of adults are now affecting children as well. Outcomes related to childhood obesity include hypertension, type 2 diabetes mellitus, dyslipidemia, left ventricular hypertrophy, nonalcoholic steatohepatitis, obstructive sleep apnea, and orthopedic problems (such as slipped capital-femoral epiphysis), as well as social and psychological problems.1 Obesity is also the most common nutritional problem among children in developed countries. This epidemic of pediatric obesity has resulted in great concern regarding the management of obesity and its complications. Although prevention would be an optimum strategy, it may be difficult to identify children at risk of obesity before they become overweight. Even with appropriate preventive approaches, it is likely that many children will become overweight and require treatment to prevent the long-term sequelae of obesity, such as cardiovascular morbidity and mortality.2
In concert with the increasing prevalence of obesity in children, pediatric hypertension has undergone an epidemiological shift. The conventional wisdom has been that hypertension in children is a relatively rare condition most commonly associated with renal disease. In actuality, secondary hypertension in children resulting from renal disease has become far less common than that related to primary (ie, essential) hypertension. In a large pediatric hypertension practice, the typical patient demographic has evolved into an otherwise healthy adolescent with obesity and some combination of the cardiovascular risk factors associated with obesity, including a family history of hypertension and an ethnic predisposition to hypertensive disease. The general topic of obesity hypertension has previously undergone comprehensive review.3 The goal of this current review will be to focus specifically on available data on the epidemiology, pathophysiology, sequelae, and management of obesity-related hypertension in children.
|
Epidemiology |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
In the United States, the prevalence and severity of overweight status is clearly increasing among children. In national surveys from the 1960s to the 1990s, the prevalence of overweight in children grew from 5% to 11%.4 Furthermore, Morrison et al5 showed that much of the increase in body mass index (BMI) in grade school–aged children between the 1970s and 1990 occurred in children between the 50th to 100th percentiles. This increase in the severity of obesity has also translated into an increase in the prevalence of outcomes such as type 2 diabetes mellitus and hypertension. A hospital-based study by Pinhas-Hamiel et al6 reported a 10-fold increase in the prevalence of newly diagnosed type 2 diabetes mellitus in adolescents from 1982 to 1994. The average BMI in this group was 37 kg/m2. Similarly, Leupker et al7 found a concordant increase in BMI and systolic blood pressure in middle school students, aged 10 to 14 years, from 1986 to 1996.
This association between obesity and hypertension in children has been reported in numerous studies among a variety of ethnic and racial groups, with virtually all studies finding higher blood pressures and/or higher prevalences of hypertension in obese compared with lean children.8–14 The most comprehensive study by Rosner et al15 pooled data from 8 large US epidemiological studies involving over 47 000 children to describe the blood pressure differences between black and white children in relation to body size. Irrespective of race, gender, or age, the risk of elevated blood pressure was significantly higher for children in the upper compared with the lower decile of BMI, with an odds ratio of systolic hypertension ranging from 2.5 to 3.7. Freedman et al12 reported that overweight children in the Bogalusa Heart Study were 4.5 and 2.4 times as likely to have elevated systolic blood pressure and diastolic blood pressure, respectively. Sorof et al14 recently reported a 3 times greater prevalence of hypertension in obese compared with nonobese adolescents in a school-based hypertension and obesity screening study.
The early clinical course of obesity hypertension appears to be characterized by a preponderance of isolated systolic hypertension (systolic hypertension without diastolic hypertension). Data from a recent multicenter trial of an antihypertensive medication in children showed that among all 140 subjects who enrolled in the trial, 37% had isolated systolic hypertension alone. The prevalence of isolated systolic hypertension was 50% (25/50) in obese subjects compared with 30% (27/90) in nonobese subjects (P=0.02).16 In the school-based screening for hypertension and obesity by Sorof et al,14 the prevalence of isolated systolic hypertension among adolescents who were obese and had blood pressure above the 95th percentile on a single set of measurements was 94%. Because isolated systolic hypertension has been shown to be a major risk factor for cardiovascular morbidity and mortality in adults,17 further investigation of the causes and interventions for this pattern in children is clearly needed.
The classification of weight status into dichotomous categories of "obese" or "nonobese" is clinically useful for characterizing the overall risk of hypertension from obesity. However, these arbitrary percentile-based categories of body habitus preclude more detailed examination of the risk relationship between adiposity and blood pressure. In fact, the risk of hypertension in children increases across the entire range of BMI values and is not defined by a simple threshold effect. Rosner et al15 reported a linear increase in the prevalence of diastolic hypertension in children of all race, gender, and age combinations as BMI increased across the "normal" range. Similarly, Sorof et al14 found an increased prevalence of systolic hypertension (based on a single set of measurements) as BMI percentile increased from the 5th to the 95th percentile (Figure 1). Among all demographic and clinical factors analyzed, BMI was most strongly associated with hypertension.
|
The dichotomous classification of blood pressure status into "hypertensive" or "normotensive" is similarly restrictive. Blood pressure is a continuous variable that is positively correlated with cardiovascular risk across the entire blood pressure range. As an example, studies of normotensive and hypertensive children have reported that blood pressure and left ventricular mass index are positively associated across a wide range of blood pressure values.18–21 Furthermore, elevated left ventricular mass may be present even in children whose blood pressure values fall within the so-called "normotensive" range. Although a child’s current blood pressure may fall within the population-based range of normality, a previously undetected pattern of relative increases in blood pressure across percentile lines over time may still effectively render that patient "hypertensive."22 This is consistent with the observation that children with high normal blood pressure during adolescence have a greater tendency to develop hypertension during adulthood.23
Nonetheless, many health care providers underdiagnose hypertension in children. Unlike in adults, in whom the definition and severity of hypertension are defined by straightforward threshold values based on the risk of outcomes, children require a separate threshold of blood pressure normality at each stage of physical maturity because of the normal age and height-related rise in blood pressure throughout childhood. The most recent Update24 from the Task Force on Hypertension Control in Children and Adolescents provided population-based percentiles for blood pressure values in children adjusted for age, gender, and height. Values that exceed the 90th and 95th percentiles are defined as "high normal blood pressure" and "hypertension," respectively. Thus, the identification of the blood pressure threshold for hypertension in a child first requires determination of height percentile, followed by interpretation of a dense table of blood pressure values with a separate threshold for each combination of gender, age, and height percentile. It is important to note that there are no normative blood pressure standards that account for weight or BMI in children. There is compelling evidence that overweight status and elevated blood pressure are closely related and synergistically increase cardiovascular risk. Adjustment of blood pressure norms based on increased weight would therefore inappropriately control for the pathologic influence of overweight on blood pressure.
Because these tables are not always used in everyday practice, mild-to-moderate hypertension may go unrecognized. As an example, although an average sized 10-year-old boy with a persistent systolic blood pressure of 120 mm Hg might not create concern for many primary care physicians, this value exceeds the 95th percentile and thus meets the criteria for hypertension. Although helpful as a guide for the determination of normality, this "statistical" definition of hypertension in children based on population percentiles must ultimately be replaced by an evidence-based definition that links specific levels of blood pressure with outcome.
The accurate measurement of blood pressure in obese children may be particularly challenging because of the absence of blood pressure cuffs that are of appropriate length and width for the upper arm of a small obese patient. Larger-than-appropriate cuff size can give falsely low measurements, whereas a smaller one can give falsely high readings.25,26 This issue is of particular importance in children because of significant differences in arm sizes at various ages. The most important issue for measuring blood pressure in the obese is choosing the correct cuff-width:arm-circumference ratio.27 The most recent Update24 to the Task Force recommends that an appropriate cuff size should have a bladder width that is approximately 40% of the arm circumference midway between the olecranon and the acromion processes (Figure 2).
|
|
Pathophysiology |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
Although the majority of data on the pathophysiology of obesity hypertension are derived from studies of animals and adults, the mechanisms of obesity hypertension have been studied in children as well. Most studies of children have focused on investigation of 3 main pathophysiological mechanisms: disturbances in autonomic function, insulin resistance, and abnormalities in vascular structure and function. Although obesity-induced hypertension is likely due to an overlap or combination of these factors,28 systematic review of the data consistent with each mechanism is useful for understanding how they may contribute to the early stages of the disease process in children.
The link between obesity and hypertension may be mediated in part by sympathetic nervous system (SNS) hyperactivity. This state of hyperactivity may include cardiovascular manifestations such as increased heart rate and blood pressure variability, neurohumeral manifestations such as increased levels of plasma catecholamines, and neural manifestations such as increased peripheral sympathetic nerve traffic. Consistent with the SNS hyperactivity hypothesis, the Bogalusa Heart Study reported that, in a biracial group of children, resting heart rate was positively correlated with blood pressure and subcapsular skinfold thickness29 and a hyperdynamic cardiovascular state was positively associated with several measures of obesity.30 Similarly, Sorof et al14 reported from school-based screening for obesity and hypertension that obese hypertensive adolescents had the highest resting heart rate and nonobese normotensive adolescents had the lowest heart rate (Figure 3). When the analysis was restricted to only those who were hypertensive, a higher heart rate was observed in the obese compared with nonobese adolescents. Rocchini et al31 found that weight loss, with or without exercise, resulted in a significant reduction in heart rate in obese adolescents.
|
Obese children are also reported to have increased heart rate variability32 and blood pressure variability14 compared with nonobese children. Evidence suggests that the increased heart rate variability in obese children may be due to an altered balance between parasympathetic and sympathetic activity and not due exclusively to increased sympathetic activity. Using time- and frequency-domain heart rate variability analysis, 24-hour blood pressure and heart rate monitoring in obese normotensive children has shown an increase in heart rate and in blood pressure associated with decreased parasympathetic heart rate control.33 Furthermore, physical training in obese children appears to alter autonomic function by reducing the ratio of sympathetic to parasympathetic activity.34 These data suggest that autonomic function has an important mediating role in the pathogenesis of obesity hypertension in children as well as in adults.
Insulin resistance has been implicated in the pathogenesis of obesity-related hypertension in children. Several studies have reported positive associations between fasting insulin levels and resting blood pressure in obese children and young adults.35–40 Nonetheless, this association does not necessarily indicate causation. Lughetti et al41 studied 350 obese children who were categorized as hypertensive or normotensive. Although insulin was significantly higher in hypertensive than in normotensive children, the difference was not clinically relevant. Furthermore, insulin explained only a small amount of systolic and diastolic blood pressure variance, which disappeared after accounting for the confounding effects of age, weight, or other anthropometric dimensions. Weight loss in obese adolescents has also been shown to result in reductions in serum insulin levels and blood pressure31,42 and to render previously salt-sensitive individuals insensitive to the hypertensive effects of salt-loading.43 Based on these data, it has been suggested that the insulin resistance associated with obesity may prevent insulin-induced glucose uptake but leave the renal sodium retention effects of insulin relatively preserved, thereby resulting in chronic volume overload and maintenance of blood pressure elevation. However, Csabi et al44 found no relationship between insulin levels and reduced sodium excretion in obese children. Thus, a causal role of insulin resistance in the pathogenesis of obesity hypertension remains uncertain.
Altered vascular structure and function may also contribute to the pathogenesis of obesity hypertension. Ultrasound of the carotid artery has demonstrated increased intimal-medial thickness in diabetic children45,46 and children with familial hypercholesterolemia,47–49 compared with normal controls. In addition, decreased vascular compliance has been reported in diabetic children50 and children with familial hypercholesterolemia.51 Similar vasculopathy has been found in obese children, in whom less severe metabolic disturbances such as glucose intolerance and dyslipidemia are common. Tounian et al52 reported lower arterial compliance, lower distensibility, and lower endothelium-dependent and -independent function in severely obese compared with control children. Similarly, Rocchini et al demonstrated decreased maximal forearm blood flow and increased minimum forearm vascular resistance in obese adolescents,53 which was improved after weight loss.54
Although these data have provided insight into the potential mechanisms of obesity hypertension in children, truly mechanistic studies illustrating the pathophysiology of the early stages of the disease process have yet to be performed. To some extent, the vulnerability of the pediatric population from a research standpoint has been a barrier to performing studies such as neurography to measure peripheral sympathetic nerve traffic or interventional studies such as hyperinsulinemic euglycemic clamping. However, the acuity of the problem would argue for an expanded role for mechanistic studies in children to identify therapeutic interventions that may interrupt the disease process before the establishment of potentially irreversible sequelae.
|
Cardiovascular Risk Factors and Complications |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
The complications of obesity that are associated with cardiovascular disease include hypertension, dyslipidemia, insulin resistance, glucose intolerance, type 2 diabetes mellitus, left ventricular hypertrophy, and pulmonary hypertension resulting from obstructive sleep apnea.55 Many of these outcomes of obesity have traditionally been viewed as problems of adulthood. However, further study has revealed that many of these abnormalities may begin in childhood and adolescence.
Obesity in children has been associated with the development of early myocardial changes and coronary and carotid artery pathology. Kortelainen evaluated the autopsies of 210 children aged 5 to 15 years who had suffered a violent death.56 Ponderal index was a significant predictor of heart weight and the presence of coronary artery intimal fatty streaks. Similarly, Berenson et al57 demonstrated in the Bogalusa Heart Study that children and young adults who died primarily of trauma showed an association between BMI, systolic blood pressure, diastolic blood pressure, and the presence of fatty streaks and fibrous plaques in the aorta and coronary arteries at autopsy. Gidding et al58 studied by electron beam computed tomography 29 patients aged 11 to 23 years with familial hypercholesterolemia to evaluate the presence of coronary artery calcium. Coronary artery calcium deposits were found in 7 of 29 subjects and were associated with increased body mass index. Sorof et al59 measured carotid intimal-medial thickness by duplex vascular ultrasound in children and adolescents with essential hypertension to assess for evidence of early arterial changes. Carotid intimal-medial thickness was positively correlated with weight, BMI, and left ventricular mass index, but not with height or age.
Left ventricular hypertrophy has been shown to be an independent risk factor for cardiovascular disease morbidity and mortality.60 In children and adolescents, left ventricular mass is determined by body size, assessed both by growth (height) and weight (adiposity). Urbina et al61 reported that the major factor influencing left ventricular mass in the Bogalusa Heart Study was linear growth determined by height, but that measures of ponderosity were also significant determinants of LVM. Daniels et al21 reported that lean body mass was the strongest determinant of LVM, but that fat mass and systolic blood pressure were also significant predictors of LVM. In adolescents with essential hypertension, Daniels et al62 found severe LVH in 14% of subjects, with greater body mass index one of the major factors associated with increased LVM. A recent study of 115 children undergoing evaluation for hypertension found an overall prevalence of LVH of 38%.63 This shows that LVH can occur early in the course of hypertension in young individuals. Patients with LVH were heavier and had greater BMI than those without LVH, and LVMI was positively correlated with BMI. These findings suggest that the combination of obesity, hypertension, and other risk factors for cardiovascular disease presents a particularly adverse profile for ultimate cardiovascular outcomes.
Obesity early in life appears to increase the likelihood of clustering of cardiovascular risk factors. In a study of adolescent girls, Morrison et al64 found that almost 11% of overweight white girls and 65% of overweight black girls had three cardiovascular risk factors compared with an expected frequency of 0.8%. Similar findings were reported for boys.65 The distribution of fat may also be important. Daniels et al21 evaluated the effects of fat distribution on risk factors for cardiovascular disease in adolescents. A more central deposition of fat (android pattern) was associated with elevation of triglycerides, decreased HDL cholesterol, increased systolic blood pressure, and increased LV mass. These relationships persisted after controlling for other variables such as age, race, gender, and height. The most compelling evidence of cardiovascular risk factor clustering in youth comes from the Bogalusa autopsy study, in which subjects with 0, 1, 2, and 3 or 4 risk factors had, respectively, 19.1%, 30.3%, 37.9%, and 35.0% of the intimal surface covered with fatty streaks in the aorta.57
|
Management |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
Most interventions for pediatric obesity have focused on behavioral approaches to diet and physical activity to address the main components of energy balance. Although these approaches have been shown to have both short- and long-term beneficial effects on BMI in selected patients,66 such success has not been uniform. This management approach is very labor intensive and is often not covered by medical insurance.67 Other dietary approaches which have been tried include the very low calorie diet68 and the protein-modified fast.69 Although these dietary approaches can be effective in selected patients, they have also been associated with important adverse effects. Surgical approaches have been used in morbidly obese adolescents but are clearly not appropriate for a large number of patients.
The role of pharmacological management in the management of pediatric obesity has been controversial. The history of pharmacological treatment of obesity in adults is replete with problems, and there have been few well-controlled studies to show that the available drugs are well tolerated and effective for use in obese children. Many of the drug treatments that have been tried in adults have resulted in complications such as with amphetamines and fenfluramine/dexfenfluramine. This history has reinforced the debate regarding whether medications should be used to treat obesity except under the most extreme circumstances. On the one hand, obesity is a chronic problem requiring long-term management and potentially long-term exposure to the adverse effects of medications, an issue of particular concern in growing and developing children. On the other hand, evidence for the benefits of weight loss on blood pressure in children may tilt the risk-benefit balance in favor of a more aggressive management approach for the prevention of future cardiovascular disease. One medication that is currently being evaluated for treatment of obesity in adolescents is sibutramine, an inhibitor of the reuptake of serotonin and norepinephrine. However, the safety and efficacy of sibutramine in patients under 16 years of age is still unknown. Furthermore, sibutramine may be associated with increased blood pressure in some patients and is not recommended for use in patients with a history of hypertension. Orlistat is a gastrointestinal lipase inhibitor that may hold promise for safe and effective pharmacological treatment for childhood obesity.
The benefits of weight loss on blood pressure reduction in children have been investigated in both observational and interventional studies. In a retrospective study based on a 10-year period of observation, Clarke et al70 reported that children whose ponderosity increased over that period had a relative increase in blood pressure by 18 percentiles compared with their peers, whereas children whose ponderosity decreased had a relative reduction in blood pressure by 13 percentiles. The positive effect of weight loss on blood pressure in children has also been demonstrated in several interventional studies. One of the first such studies by Brownell et al71 reported blood pressure reductions of up to 16/9 mm Hg in obese children who achieved significant weight reduction after 16 months of dietary counseling. Figueroa-Colon et al72 found that blood pressure was significantly reduced compared with baseline at all points of a study comparing 2 hypocaloric dietary modifications in obese children. Wabitsch et al42 reported a blood pressure reduction of 9/5 mm Hg associated with a weight reduction of 8.5 kg after a 6-week dietary intervention in obese adolescent girls. Similarly, Gallistl et al73 reported an 8/7 mm Hg blood pressure reduction associated with weight loss of 3.9 kg after a 3-week diet and exercise program in obese children.
Although these studies suggest that blood pressure reductions are induced by weight loss in obese children, each is limited by the absence of a matched control group to show that the blood pressure reduction was directly attributable to weight loss. The only controlled trial to date was performed by Rocchini et al54 who randomized overweight adolescents to 3 interventions over a 20-week period: diet alone, diet plus exercise, and control (no intervention). Changes in systolic blood pressure from baseline in the diet plus exercise group, diet alone group, and control group were -16 mm Hg, -10 mm Hg, and +4 mm Hg, respectively. This latter study provides the most definitive evidence that weight loss, particularly in conjunction with exercise, can be beneficial in the management of obesity hypertension in children. However, the long-term benefits of weight loss on blood pressure remain to be defined because it is unknown whether the decline of blood pressure observed during acute weight loss is maintained.
|
Perspectives |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
The prevalence and severity of obesity is increasing in children and adolescents. These observations suggest that the trend of decreasing cardiovascular disease in adults observed over the past 50 years may be reversed as the current population of overweight children and adolescents become adults.74 At present, treatment for all overweight children and adolescents can be recommended based on available data. However, the methods used to achieve weight management remain controversial. It seems appropriate to reserve pharmacological therapy for children most severely affected by obesity and its sequelae. It is also appropriate to reserve such therapy for those who have failed or have had only modest success with behavioral therapy directed at dietary modification and increased physical activity. The presence of ongoing obesity-related outcomes such as hypertension, diabetes mellitus or impaired glucose tolerance, and dyslipidemia may increase the rationale for more aggressive therapy. Ultimately, multiple therapeutic strategies may be necessary to achieve the desired goal.
Obesity in childhood should be considered a chronic medical condition and, thus, is likely to require long-term treatment. Public health initiatives to educate community leaders and health care providers may prove instrumental in stemming the evolving epidemic of pediatric obesity and its complications. In addition, the scope and acuity of the problem facing our youth suggests that substantial research is needed that is focused on the mechanisms of hypertension related to obesity in the pediatric population. Such research will serve as the basis for future guidelines for prevention and treatment of obesity hypertension.
Received June 21, 2002; first decision July 17, 2002; accepted July 30, 2002.
|
References |
|---|
|
TopAbstractIntroductionEpidemiologyPathophysiologyCardiovascular Risk Factors and...ManagementPerspectivesReferences |
|---|
1. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998; 102: E29.[CrossRef][Medline] [Order article via Infotrieve]
2. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998; 97: 2099–2100.
3. Hall JE, Brands MW, Jones DW, Shek EW, Henegar JR. Mechanism of obesity hypertension and relevance to essential hypertension. In: Fletcher GF, Grundy SM, Hayman LL, eds. Obesity: Impact on Cardiovascular Disease. Armonk, NY: Futura Publishing Co Inc; 1999: 133–153.
4. Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 through 1994. Pediatrics. 1997; 99: E1.
5. Morrison JA, James FW, Sprecher DL, Khoury PR, Daniels SR. Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975–1990: the Princeton School Study. Am J Public Health. 1999; 89: 1708–1714.
6. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non–insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996; 128: 608–615.[CrossRef][Medline] [Order article via Infotrieve]
7. Luepker RV, Jacobs DR, Prineas RJ, Sinaiko AR. Secular trends of blood pressure and body size in a multiethnic adolescent population: 1986 to 1996. J Pediatr. 1999; 134: 668–674.[CrossRef][Medline] [Order article via Infotrieve]
8. Elcarte LR, Villa EI, Sada GJ, Gasco EM, Oyarzabal IM, Sola MA, Martinez GA, Elcarte LT, Ayensa MI, Castiella LF. [The Navarra study. Prevalence of arterial hypertension, hyperlipidemia and obesity in the infant-child population of Navarra. Association of risk factors]. An Esp Pediatr. 1993; 38: 428–436.[Medline] [Order article via Infotrieve]
9. Verma M, Chhatwal J, George SM. Obesity and hypertension in children. Indian Pediatr. 1994; 31: 1065–1069.[Medline] [Order article via Infotrieve]
10. Guillaume M, Lapidus L, Beckers F, Lambert A, Bjorntorp P. Cardiovascular risk factors in children from the Belgian province of Luxembourg. The Belgian Luxembourg Child Study. Am J Epidemiol. 1996; 144: 867–880.
11. Macedo ME, Trigueiros D, de Freitas F. Prevalence of high blood pressure in children and adolescents. Influence of obesity. Rev Port Cardiol. 1997; 16: 27–28.[Medline] [Order article via Infotrieve]
12. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999; 103: 1175–1182.
13. Morrison JA, Barton BA, Biro FM, Daniels SR, Sprecher DL. Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr. 1999; 135: 451–457.[CrossRef][Medline] [Order article via Infotrieve]
14. Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002; 140: 660–666.[CrossRef][Medline] [Order article via Infotrieve]
15. Rosner B, Prineas R, Daniels SR, Loggie J. Blood pressure differences between blacks and whites in relation to body size among US children and adolescents. Am J Epidemiol. 2000; 151: 1007–1019.
16. Sorof JM, Urbina EM, Cunningham RJ, Hogg RJ, Moxey-Mims M, Eissa MA, Rolf C. Screening for eligibility in the study of antihypertensive medication in children: experience from the Ziac Pediatric Hypertension Study. Am J Hypertens. 2001; 14: 783–787.[CrossRef][Medline] [Order article via Infotrieve]
17. Izzo JLJ, Levy D, Black HR. Importance of systolic blood pressure in older americans. Hypertension. 2000; 35: 1021–1024.
18. Malcolm DD, Burns TL, Mahoney LT, Lauer RM. Factors affecting left ventricular mass in childhood: the Muscatine Study. Pediatrics. 1993; 92: 703–709.
19. Treiber FA, McCaffrey F, Pflieger K, Raunikar RA, Strong WB, Davis H. Determinants of left ventricular mass in normotensive children. Am J Hypertens. 1993; 6: 505–513.[Medline] [Order article via Infotrieve]
20. Harshfield GA, Koelsch DW, Pulliam DA, Alpert BS, Richey PA, Becker JA. Racial differences in the age-related increase in left ventricular mass in youths. Hypertension. 1994; 24: 747–751.
21. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation. 1995; 92: 3249–3254.
22. Goonasekera CD, Dillon MJ. Measurement and interpretation of blood pressure. Arch Dis Child. 2000; 82: 261–265.
23. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995; 8: 657–665.[CrossRef][Medline] [Order article via Infotrieve]
24. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996; 98: 649–658.
25. Whincup PH, Cook DG, Shaper AG. Blood pressure measurement in children: the importance of cuff bladder size. J Hypertens. 1989; 7: 845–850.[CrossRef][Medline] [Order article via Infotrieve]
26. Gomez-Marin O, Prineas RJ, Rastam L. Cuff bladder width and blood pressure measurement in children and adolescents. J Hypertens. 1992; 10: 1235–1241.[CrossRef][Medline] [Order article via Infotrieve]
27. Prineas RJ. Measurement of blood pressure in the obese. Ann Epidemiol. 1991; 1: 321–336.[Medline] [Order article via Infotrieve]
28. Rocchini AP. Obesity hypertension. Am J Hypertens. 2002; 15: 50S–52S.[CrossRef][Medline] [Order article via Infotrieve]
29. Voors AW, Webber LS, Berenson GS. Resting heart rate and pressure-rate product of children in a total biracial community. The Bogalusa Heart Study. Am J Epidemiol. 1982; 116: 276–286.
30. Jiang X, Srinivasan SR, Urbina E, Berenson GS. Hyperdynamic circulation and cardiovascular risk in children and adolescents. The Bogalusa Heart Study. Circulation. 1995; 91: 1101–1106.
31. Rocchini AP, Katch V, Schork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension. 1987; 10: 267–273.
32. Riva P, Martini G, Rabbia F, Milan A, Paglieri C, Chiandussi L, Veglio F. Obesity and autonomic function in adolescence. Clin Exp Hypertens. 2001; 23: 57–67.[CrossRef][Medline] [Order article via Infotrieve]
33. Martini G, Riva P, Rabbia F, Molini V, Ferrero GB, Cerutti F, Carra R, Veglio F. Heart rate variability in childhood obesity. Clin Auton Res. 2001; 11: 87–91.[CrossRef][Medline] [Order article via Infotrieve]
34. Gutin B, Owens S, Slavens G, Riggs S, Treiber F. Effect of physical training on heart-period variability in obese children. J Pediatr. 1997; 130: 938–943.[CrossRef][Medline] [Order article via Infotrieve]
35. Voors AW, Radhakrishnamurthy B, Srinivasan SR, Webber LS, Berenson GS. Plasma glucose level related to blood pressure in 272 children, ages 7–15 years, sampled from a total biracial population. Am J Epidemiol. 1981; 113: 347–356.
36. Kanai H, Matsuzawa Y, Tokunaga K, Keno Y, Kobatake T, Fujioka S, Nakajima T, Tarui S. Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure. Int J Obes. 1990; 14: 1047–1056.[Medline] [Order article via Infotrieve]
37. Saito I, Nishino M, Kawabe H, Wainai H, Hasegawa C, Saruta T, Nagano S, Sekihara T. Leisure time physical activity and insulin resistance in young obese students with hypertension. Am J Hypertens. 1992; 5: 915–918.[Medline] [Order article via Infotrieve]
38. Pozzan R, Brandao AA, da Silva SL, Brandao AP. Hyperglycemia, hyperinsulinemia, overweight, and high blood pressure in young adults. The Rio de Janeiro Study. Hypertension. 1997; 30: 650–653.
39. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1999; 150: 667–674.
40. Young-Hyman D, Schlundt DG, Herman L, De Luca F, Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care. 2001; 24: 1359–1364.
41. Lughetti L, Bedogni G, Ferrari M, Pagliato E, Manzieri AM, De Simone M, Battistini N, Bernasconi S. Is fasting insulin associated with blood pressure in obese children? Ann Hum Biol. 2000; 27: 499–506.[CrossRef][Medline] [Order article via Infotrieve]
42. Wabitsch M, Hauner H, Heinze E, Muche R, Bockmann A, Parthon W, Mayer H, Teller W. Body-fat distribution and changes in the atherogenic risk-factor profile in obese adolescent girls during weight reduction. Am J Clin Nutr. 1994; 60: 54–60.
43. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989; 321: 580–585.[Abstract]
44. Csabi G, Molnar D, Hartmann G. Urinary sodium excretion: association with hyperinsulinaemia, hypertension and sympathetic nervous system activity in obese and control children. Eur J Pediatr. 1996; 155: 895–897.[Medline] [Order article via Infotrieve]
45. Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care. 1998; 21: 1004–1007.[Abstract]
46. Jarvisalo MJ, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, Raitakari OT. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002; 51: 493–498.
47. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, Bonaa KH. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996; 16: 984–991.
48. Jarvisalo MJ, Jartti L, Nanto-Salonen K, Irjala K, Ronnemaa T, Hartiala JJ, Celermajer DS, Raitakari OT. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation. 2001; 104: 2943–2947.
49. Virkola K, Pesonen E, Akerblom HK, Siimes MA. Cholesterol and carotid artery wall in children and adolescents with familial hypercholesterolaemia: a controlled study by ultrasound. Acta Paediatr. 1997; 86: 1203–1207.[Medline] [Order article via Infotrieve]
50. Parikh A, Sochett EB, McCrindle BW, Dipchand A, Daneman A, Daneman D. Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr. 2000; 137: 465–469.[CrossRef][Medline] [Order article via Infotrieve]
51. Aggoun Y, Bonnet D, Sidi D, Girardet JP, Brucker E, Polak M, Safar ME, Levy BI. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2000; 20: 2070–2075.
52. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001; 358: 1400–1404.[CrossRef][Medline] [Order article via Infotrieve]
53. Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension. 1992; 19: 615–620.
54. Rocchini AP, Katch V, Anderson J, Hinderliter J, Becque D, Martin M, Marks C. Blood pressure in obese adolescents: effect of weight loss. Pediatrics. 1988; 82: 16–23.
55. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998; 101: 518–525.
56. Kortelainen ML. Adiposity, cardiac size and precursors of coronary atherosclerosis in 5- to 15-year-old children: a retrospective study of 210 violent deaths. Int J Obesity. 1997; 21: 691–697.[CrossRef]
57. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998; 338: 1650–1656.
58. Gidding SS, Bookstein LC, Chomka EV. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation. 1998; 98: 2580–2583.
59. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2002; In press.
60. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561–1566.[Abstract]
61. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995; 91: 2400–2406.
62. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension (see comments). Circulation. 1998; 97: 1907–1911.
63. Sorof JM, Hanevold C, Portman RJ, Daniels SR. Left ventricular hypertrophy in hypertensive children: a Report from the International Pediatric Hypertension Association. Am J Hypertens. 2002; 15: 31A–31A.Abstract.
64. Morrison JA, Sprecher DL, Barton BA, Waclawiw MA, Daniels SR. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 1999; 135: 458–464.[CrossRef][Medline] [Order article via Infotrieve]
65. Morrison JA, Barton BA, Biro FM, Daniels SR, Sprecher DL. Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr. 1999; 135: 451–457.[CrossRef][Medline] [Order article via Infotrieve]
66. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA. 1990; 264: 2519–2523.
67. Tershakovec AM, Watson MH, Wenner WJJ, Marx AL. Insurance reimbursement for the treatment of obesity in children. J Pediatr. 1999; 134: 573–578.[CrossRef][Medline] [Order article via Infotrieve]
68. Very low-calorie diets. National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health. JAMA. 1993; 270: 967–974.
69. Bistrian BR. Clinical use of a protein-sparing modified fast. JAMA. 1978; 240: 2299–2302.
70. Clarke WR, Woolson RF, Lauer RM. Changes in ponderosity and blood pressure in childhood. The Muscatine Study. Am J Epidemiol. 1986; 124: 195–206.
71. Brownell KD, Kelman JH, Stunkard AJ. Treatment of obese children with and without their mothers: changes in weight and blood pressure. Pediatrics. 1983; 71: 515–523.
72. Figueroa-Colon R, von Almen TK, Franklin FA, Schuftan C, Suskind RM. Comparison of two hypocaloric diets in obese children. Am J Dis Child. 1993; 147: 160–166.
73. Gallistl S, Sudi KM, Aigner R, Borkenstein M. Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program. Int J Obes Relat Metab Disord. 2001; 25: 1640–1643.[CrossRef][Medline] [Order article via Infotrieve]
74. Daniels SR. Is there an epidemic of cardiovascular disease on the horizon? J Pediatr. 1999; 134: 665–666.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  N. J. Farpour-Lambert, Y. Aggoun, L. M. Marchand, X. E. Martin, F. R. Herrmann, and M. Beghetti Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J. Am. Coll. Cardiol., December 15, 2009; 54(25): 2396 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Maximova, J. O'Loughlin, G. Paradis, J. A. Hanley, and J. Lynch Declines in Physical Activity and Higher Systolic Blood Pressure in Adolescence Am. J. Epidemiol., November 1, 2009; 170(9): 1084 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, P. Pokala, L. Hill, K. N. Boutelle, C. Wood, K. Becerra, and K. Calfas The Health and Obesity: Prevention and Education (HOPE) Curriculum Project--Curriculum Development Pediatrics, November 1, 2009; 124(5): 1438 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ataei, M. Hosseini, and M. Iranmanesh The Relationship of Body Mass Index and Blood Pressure in Iranian Children <7 Years Old J Trop Pediatr, October 1, 2009; 55(5): 313 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Martinez-Gomez, J. Tucker, K. A. Heelan, G. J. Welk, and J. C. Eisenmann Associations Between Sedentary Behavior and Blood Pressure in Young Children Arch Pediatr Adolesc Med, August 1, 2009; 163(8): 724 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barton and M. R. Meyer Postmenopausal Hypertension: Mechanisms and Therapy Hypertension, July 1, 2009; 54(1): 11 - 18. [Full Text] [PDF]
|
|
|
|
|
|
E. Lurbe, E. Carvajal, I. Torro, F. Aguilar, J. Alvarez, and J. Redon Influence of Concurrent Obesity and Low Birth Weight on Blood Pressure Phenotype in Youth Hypertension, June 1, 2009; 53(6): 912 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barton, E. Haas, and I. Bhattacharya Getting Radical About Obesity: New Links Between Fat and Heart Disease Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 447 - 448. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Jerrell and R. S. McIntyre Cardiovascular and Neurological Adverse Events Associated With Antidepressant Treatment in Children and Adolescents J Child Neurol, March 1, 2009; 24(3): 297 - 304. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Steinberger, S. R. Daniels, R. H. Eckel, L. Hayman, R. H. Lustig, B. McCrindle, and M. L. Mietus-Snyder Progress and Challenges in Metabolic Syndrome in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism Circulation, February 3, 2009; 119(4): 628 - 647. [Full Text] [PDF]
|
|
|
|
|
|
L. Benson, H. J. Baer, and D. C. Kaelber Trends in the Diagnosis of Overweight and Obesity in Children and Adolescents: 1999-2007 Pediatrics, January 1, 2009; 123(1): e153 - e158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. McIntyre and J. M. Jerrell Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents Arch Pediatr Adolesc Med, October 1, 2008; 162(10): 929 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salvadori, J. M. Sontrop, A. X. Garg, J. Truong, R. S. Suri, F. H. Mahmud, J. J. Macnab, and W. F. Clark Elevated Blood Pressure in Relation to Overweight and Obesity Among Children in a Rural Canadian Community Pediatrics, October 1, 2008; 122(4): e821 - e827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Velkoska, T. J. Cole, R. G. Dean, L. M. Burrell, and M. J. Morris Early Undernutrition Leads to Long-Lasting Reductions in Body Weight and Adiposity Whereas Increased Intake Increases Cardiac Fibrosis in Male Rats J. Nutr., September 1, 2008; 138(9): 1622 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Wang, J Necheles, M Carnethon, B Wang, Z Li, L Wang, X Liu, J Yang, G Tang, H Xing, et al. Adiposity measures and blood pressure in Chinese children and adolescents Arch. Dis. Child., September 1, 2008; 93(9): 738 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Benjamin Jr, P. B. Smith, P. Jadhav, J. V. Gobburu, M. D. Murphy, V. Hasselblad, C. Baker-Smith, R. M. Califf, and J. S. Li Pediatric Antihypertensive Trial Failures: Analysis of End Points and Dose Range Hypertension, April 1, 2008; 51(4): 834 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu, W. Yan, D. Ge, F. A. Treiber, G. A. Harshfield, G. Kapuku, H. Snieder, and Y. Dong Relationships of Cardiovascular Phenotypes With Healthy Weight, at Risk of Overweight, and Overweight in US Youths Pediatrics, January 1, 2008; 121(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Pinto, B. S. Marino, G. Wernovsky, S. D. de Ferranti, A. Z. Walsh, M. Laronde, K. Hyland, S. O. Dunn Jr, and M. S. Cohen Obesity Is a Common Comorbidity in Children With Congenital and Acquired Heart Disease Pediatrics, November 1, 2007; 120(5): e1157 - e1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gilbert and M. F. Fleming Use of Enhanced Body Mass Index Charts During the Pediatric Health Supervision Visit Increases Physician Recognition of Overweight Patients Clinical Pediatrics, October 1, 2007; 46(8): 689 - 697. [Abstract] [PDF]
|
|
|
|
|
|
L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism Circulation, July 17, 2007; 116(3): 344 - 357. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Huang, K. Becerra, T. Oda, E. Walker, R. Xu, M. Donohue, I. Chen, V. Curbelo, and A. Breslow Parental Ability to Discriminate the Weight Status of Children: Results of a Survey Pediatrics, July 1, 2007; 120(1): e112 - e119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Faigenbaum State of the Art Reviews: Resistance Training for Children and Adolescents: Are There Health Outcomes? American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 190 - 200. [Abstract] [PDF]
|
|
|
|
|
|
S. Stranges and F. P Cappuccio Children under pressure: an underestimated burden? Arch. Dis. Child., April 1, 2007; 92(4): 288 - 290. [Full Text] [PDF]
|
|
|
|
|
|
A. Chiolero, P. Bovet, G. Paradis, and F. Paccaud Has Blood Pressure Increased in Children in Response to the Obesity Epidemic? Pediatrics, March 1, 2007; 119(3): 544 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Tarlton Prevalence of Elevated Blood Pressure in Hispanic Versus Non-Hispanic 6th Graders The Journal of School Nursing, February 1, 2007; 23(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Bell, S. Byrne, A. Thompson, N. Ratnam, E. Blair, M. Bulsara, T. W. Jones, and E. A. Davis Increasing Body Mass Index z-Score Is Continuously Associated with Complications of Overweight in Children, Even in the Healthy Weight Range J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 517 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Di Salvo, G. Pacileo, E. M. Del Giudice, F. Natale, G. Limongelli, M. Verrengia, A. Rea, F. Fratta, B. Castaldi, A. D'Andrea, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study Eur. Heart J., November 2, 2006; 27(22): 2689 - 2695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Sinaiko, J. Steinberger, A. Moran, C.-P. Hong, R. J. Prineas, and D. R. Jacobs Jr Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19 Hypertension, October 1, 2006; 48(4): 730 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar, S. Czernichow, and J. Blacher Obesity, Arterial Stiffness, and Cardiovascular Risk J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S109 - S111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J X Jiang, X L Xia, T Greiner, G L Lian, and U Rosenqvist A two year family based behaviour treatment for obese children Arch. Dis. Child., December 1, 2005; 90(12): 1235 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suresh, P. Mahajan, and D. Kamat Emergency Management of Pediatric Hypertension Clinical Pediatrics, November 1, 2005; 44(9): 739 - 745. [PDF]
|
|
|
|
|
|
S. Y. Tuli and V. R. Dharnidharka Utility of Renal Imaging in the Diagnostic Evaluation of Obese Childhood Primary Hypertension Clinical Pediatrics, September 1, 2005; 44(7): 589 - 592. [Abstract] [PDF]
|
|
|
|
|
|
G. S. Boyd, J. Koenigsberg, B. Falkner, S. Gidding, and S. Hassink Effect of Obesity and High Blood Pressure on Plasma Lipid Levels in Children and Adolescents Pediatrics, August 1, 2005; 116(2): 442 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Bagi, N. Erdei, A. Toth, W. Li, T. H. Hintze, A. Koller, and G. Kaley Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure: Enhanced Release of COX-2-Derived Constrictor Prostaglandins Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1610 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Dorsey, C. Wells, H. M. Krumholz, and J. C. Concato Diagnosis, Evaluation, and Treatment of Childhood Obesity in Pediatric Practice Arch Pediatr Adolesc Med, July 1, 2005; 159(7): 632 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Bunt, P. A. Tataranni, and A. D. Salbe Intrauterine Exposure to Diabetes Is a Determinant of Hemoglobin A1c and Systolic Blood Pressure in Pima Indian Children J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3225 - 3229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Paradis, M. Lambert, J. O'Loughlin, C. Lavallee, J. Aubin, E. Delvin, E. Levy, and J. A. Hanley Blood Pressure and Adiposity in Children and Adolescents Circulation, September 28, 2004; 110(13): 1832 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Li, K. Berezny, R. Kilaru, L. Hazan, R. Portman, R. Hogg, R. D. Jenkins, P. Kanani, C. M. Cottrill, T. K. Mattoo, et al. Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children? Hypertension, September 1, 2004; 44(3): 289 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
National High Blood Pressure Education Program Wor The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents Pediatrics, August 1, 2004; 114(2/S2): 555 - 576. [Full Text] [PDF]
|
|
|
|
|
|
R. Tauman, A. Ivanenko, L. M. O'Brien, and D. Gozal Plasma C-Reactive Protein Levels Among Children With Sleep-Disordered Breathing Pediatrics, June 1, 2004; 113(6): e564 - e569. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. P. Davy and J. E. Hall Obesity and hypertension: two epidemics or one? Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R803 - R813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Burke, L. J. Beilin, K. V. Blake, D. Doherty, G. E. Kendall, J. P. Newnham, L. I. Landau, and F. J. Stanley Indicators of Fetal Growth Do Not Independently Predict Blood Pressure in 8-Year-Old Australians: A Prospective Cohort Study Hypertension, February 1, 2004; 43(2): 208 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Sorof, J. Turner, D. S. Martin, K. Garcia, Z. Garami, A. V. Alexandrov, F. Wan, and R. J. Portman Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening Hypertension, February 1, 2004; 43(2): 214 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Bouziotas, Y Koutedakis, A Nevill, E Ageli, N Tsigilis, A Nikolaou, and A Nakou Greek adolescents, fitness, fatness, fat intake, activity, and coronary heart disease risk Arch. Dis. Child., January 1, 2004; 89(1): 41 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. de Paula, A. A. da Silva, and J. E. Hall Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration Hypertension, January 1, 2004; 43(1): 41 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Soriguer, G. Rojo-Martinez, M C. Dobarganes, J. M Garcia Almeida, I. Esteva, M. Beltran, M S. Ruiz De Adana, F. Tinahones, J. M Gomez-Zumaquero, E. Garcia-Fuentes, et al. Hypertension is related to the degradation of dietary frying oils Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Neter, B. E. Stam, F. J. Kok, D. E. Grobbee, and J. M. Geleijnse Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials Hypertension, November 1, 2003; 42(5): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Enright, J. L. Goodwin, D. L. Sherrill, J. R. Quan, and S. F. Quan Blood Pressure Elevation Associated With Sleep-Related Breathing Disorder in a Community Sample of White and Hispanic Children: The Tucson Children's Assessment of Sleep Apnea Study Arch Pediatr Adolesc Med, September 1, 2003; 157(9): 901 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Freedman High-fat diets and cardiovascular disease: Are nutritional supplements useful? J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1750 - 1752. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||